Related Experiment Video
Updated: Aug 5, 2026

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
Published on: March 22, 2016
Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells
I Hartl1, R M Schneider, Y Sun
1Medizinische Biotechnologie, Paul-Ehrlich-Institut, Langen, Germany.
Abstract:
Viruses conditionally replicating in cancer cells form an attractive novel class of antitumoral agents. To engineer such viruses infectivity can be coupled with proteolytic activity of the target cell by modifying the envelope (Env) protein of murine leukaemia virus (MLV) with blocking domains that prevent cell entry unless they are cleaved off by tumour-associated proteases like the matrix metalloproteases (MMP). Here we show that MLV variants selectively spreading through MMP-positive cells can be evolved from virus libraries, in which a standard MMP-2 substrate peptide connecting the blocking domain CD40L with the Env protein was diversified. Passaging the virus library on human fibrosarcoma or glioma cell lines resulted in the selection of about 10 virus clones, of which the three most frequent ones were shown to become activated by MMPs and to be replication competent on MMP-positive cells only. On these cells, the selected linker peptides improved the spreading by several orders of magnitude in vitro, as well as in tumour xenografts in vivo, approaching the kinetic of the unmodified wild-type virus. The data suggest that retroviral protease substrate libraries form a potent tool for the engineering of viruses conditionally replicating in a given cancer cell type of interest.
Insights
Engineered retroviruses selectively infect cancer cells by using tumor-specific proteases. This novel approach enhances oncolytic virus therapy by improving tumor targeting and replication in MMP-positive cancer cells.
Area of Science:
- Oncolytic virology
- Molecular engineering of retroviruses
- Cancer therapy
Background:
- Viruses that replicate conditionally in cancer cells are a promising new class of antitumoral agents.
- Engineering infectivity to match cancer cell proteolytic activity is key for targeted delivery.
Purpose of the Study:
- To engineer murine leukaemia virus (MLV) variants that selectively spread in tumors expressing matrix metalloproteinases (MMPs).
- To develop a method for creating retroviruses that are activated by tumor-specific proteases.
Main Methods:
- Diversification of MMP-2 substrate peptides within the MLV envelope (Env) protein.
- Selection of MLV variants by passaging virus libraries on human fibrosarcoma and glioma cell lines.
- Testing selected clones for MMP activation, replication competence, and spreading ability in vitro and in vivo.
Main Results:
- Selection yielded MLV variants activated by MMPs, replicating exclusively in MMP-positive cells.
- Selected linker peptides significantly improved virus spreading in vitro and in vivo tumor xenografts.
- Engineered virus spreading approached that of the wild-type virus.
Conclusions:
- Retroviral protease substrate libraries are effective for engineering conditionally replicating oncolytic viruses.
- This strategy allows for targeted cancer cell killing by coupling virus infectivity to tumor-specific protease activity.
- The developed MLV variants show potential for enhanced oncolytic virotherapy in MMP-expressing cancers.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Mechanisms of Retrovirus-induced Cancers
Size and Structure of Viral Genomes
Viruses with RNA Genomes
Inhibitors of Virion Maturation and Assembly

